 |
Aclasta: Zolendronic acid for OsteoporosisAclasta is another drug using zoledronic acid. Like Reclast and Zometa, this drug is given ih a once a year infusion. The drug is manufactured by Novartis, one of the largest pharmaceutical companies. The drug was approved by the FDA after a three year study called the Pivotal Fracture Trial, which showed that this drug increased bone strength and reduced fractures of the hip, spine and other areas such as wrist, arm, leg, rib. It is claimed that the drug is the only treatment shown to reduce fractures at all these key sites. A report in the New England Journal of Medicine in May 2007 stated that in a study involving more than 7,700 women Aclasta reduced the risk of spine fractures by 70% and hip fractures by 41%. The reduction in spine fractures for the three years was as follows:
A spokesperson for Novatis said of this drug, "(It) has shown significant efficacy in protecting women against fractures in It is believed that once a year infusions will be an effective remedy for the main problem with daily, weekly or monthly medications. the Health Care industry has found that people just stop taking these daily, weekly and monthly medications. (This is called 'non-compliance' in the medical community) Side effects Since this drug is sold under various names in different countries, the same side effects would apply to it as apply to the drug under its other name, Reclast. In fact, if you live in the United States, the Novartis site directsyour to the page about Reclast. If you want to know the potential side effect of this drug, go to this web page and just scroll down to Aclasta, Reclast Side Effects If you are interested in reading about some natural treatments forbone loss, do go to Natural Osteopenia, Osteoporosis Treatments In particular you may want to read the research about natural supplements of Strontium for stronger bones |